2. Stanley HR. Aphthous lesions. Oral Surg Oral Med Oral Pathol
1972;33:407–16.
3. Jurge S, Kuffer R, Scully C, Porter SR. Number VI recurrent
aphthous stomatitis. Oral Dis 2006;12 :1–21.
4. Axell T, Henricsson V. The occurrence of recurrent
aphthous ulcers in an adult Swedish population. Ada Odontol
Scand 1985;43:121–5.
5. Natah SS, Konttine n YT, Enattah NS, et al. Recurrent
aphthous ulcers today: a review of the growing knowledge.
Int J Oral Maxillofac Surg 2004;33:221–34.
6. Ship II. Epidemiologic aspects of recurrent aphthous
ulcerations. Oral Surg Oral Med Oral Pathol 1972;33:
400–6.
7. Miller MF, Ship II. A retrospective study of the prevalence
and incidence of recurrent aphthou s ulcers in a professional
population, 1958–1971. Oral Surg Oral Med Oral Pathol
1977;43:532–7.
8. McCartan BE, Lamey PJ, Wallace AM. Salivary cortisol and
anxiety in recurrent aphthous stomatitis. J Oral Pathol Med
1996;25:357–9.
9. Victoria JM, Correia-Silva JF, Pimenta FJ, Kalapothakis E,
Gomez RS. Serotonin transporter gene polymorphism (5-
HTTLPR) in patients with recurrent aphthous stomatitis. J
Oral Pathol Med 2005;34:494–7.
10. Borra RC, Andrade PM, Silva ID, et al. The Th1/Th2 immune-
type response of the recurrent aphthous ulceration
analyzed by cDNA microarray. J Oral Pathol Med 2004;33:
140–6.
11. Lewkowicz N, Lewkowicz P, Banasik M, Kurnatowska A,
Tchorzewski H. Predominance of Type 1 cytokines and
decreased number of CD4(+)CD25(+high) T regulatory cells
in peripheral blood of patients with recurrent aphthous
ulcerations. Immunol Lett 2005;99:57–62.
12. Buno IJ, Huff JC, Weston WL, Cook DT, Brice SL. Elevated
levels of interferon gamma, tumor necrosis factor alpha,
interleukins 2, 4 and 5, but not interleukin 10, are present
in recurrent aphthous stomatitis. Arch Dermatol
1998;134:827–31.
13. Pociot F, Molvig J, Wogensen L, Worsaae H, Nerup J. A Taql
polymorphism in the human interleukin-1 beta (IL-1 beta)
gene correlates with IL-1 beta secretion in vitro. Eur J Clin
Invest 1992;22:396–402.
14. Wilson AG, Symons JA, McDowell TL, McDevitt HO, Duff
GW. Effects of a polymorphism in the human tumor
necrosis factor alpha promoter on transcriptional
activation. Proc Natl Acad Sci USA 1997;94:3195–9.
15. Bazrafshani MR, Hajeer AH, Ollier WE, Thornhill MH. IL-1b
and IL-6 gene polymorphisms encode significant risk for the
development of recurrent aphthous stomatitis (RAS). Genes
Immun 2002;3:302–5.
16. Parra FC, Amado RC, Lambertucci JR, et al. Color and
genomic ancestry in Brazilians. Proc Natl Acad Sci USA
2003;100:177–82.
17. Ship JA, Chavez EM, Doerr PA, Henson BS, Sarmadi M.
Recurrent aphthous stomatitis. Quintessence Int 2000;31:
95–112.
18. Guimaraes AL, de Sa AR, Victoria JM, et al. Interleukin-1 B
and serotonin transporter gene polymorphisms in Burning
Mouth Syndrome patients. J Pain 2006;9:654–8.
19. Natah SS, Hayrinen-Immonen R, Hietanen J, Malmstrom M,
Konttinen YT. Immunolocalization of tumor necrosis
factor-alpha expressing cells in recurrent aphthous ulcer
lesions (RAU). J Oral Pathol Med 2000;29:19–25.
20. Lewkowicz N, Lewkowicz P, Kurnatowska A, et al. Innate
immune system is implicated in recurrent aphthous ulcer
pathogenesis. J Oral Pathol Med 2003;32:475–81.
21. Lang NP, Tonetti MS, Suter J, et al. Effect of interleukin-1
gene polymorphisms on gingival inflammation assessed by
bleeding on probing in a periodontal maintenance
population. J Periodontal Res 2000;35:102–7.
22. Dagia NM, Goetz DJ. A proteasome inhibitor reduces
concurrent, sequential, and long-term IL-1 beta- and TNF-
alpha-induced ECAM expression and adhesion. Am J Physiol
Cell Physiol 2003;285:C813–22.
23. Healy CM, Enobakhare B, Haskard DO, Thornhill MH. Raised
levels of circulating VCAM-1 and circulating E-selectin in
patients with recurrent oral ulceration. J Oral Pathol Med
1997;26:23–8.
24. Maes M, Bosmans E, Suy E, et al. Depression-related
disturbances in mitogen-induced lymphocyte responses
and interleukin-1 beta and soluble interleukin-2 receptor
production. Ada Psychiatr Scand 1991;84:379–86.
25. Maes M, Bosmans E, Suy E, Minner B, Raus J. A further
exploration of the relationships between immune
parameters and the HPA-axis activity in depressed patients.
Psychol Med 1991;21:313–20.
26. Rosa A, Peralta V, Papiol S, et al. Interleukin-1 beta (IL-1
beta) gene and increased risk for the depressive symptom-
dimension in schizophrenia spectrum disorders. Am J Med
Genet B Neuropsychiatr Genet 2004;124:10–4.
27. Bazrafshani MR, Hajeer AH, Ollier WE, Thornhill MH.
Recurrent aphthous stomatitis and gene polymorph isms for
the inflammatory markers TNF-alpha , TNF-beta and the
Vitamin D receptor: no association detected. Oral Dis
2002;8:303–7.
28. Taylor LJ, Bagg J, Walker DM, Peters TJ. Increased production
of tumour necrosis factor by peripheral blood leukocytes in
patients with recurrent oral aphthous ulceration. J Oral
Pathol Med 1992;21:21–5.
29. Dolby AE. Recurrent aphthous ulceration. Effect of sera and
peripheral blood lymphocytes upon oral epithelial tissue
culture cells. Immunology 1969;17:709–14.
30. Sampaio EP, Sarno EN, Galilly R, Cohn ZA, Kaplan G.
Thalidomide selectively inhibits tumor necrosis factor alpha
production by stimulated human monocytes. J Exp Med
1991;173:699–703.
31. Sun A, Chia JS, Chang YF, Chiang CP. Levamisole and
Chinese medicinal herbs can modulate the serum
interleukin-6 level in patients with recurrent aphthous
ulcerations. J Oral Pathol Med 2003;32:206–14.
32. Klein W, Tromm A, Griga T, et al. The polymorphism at
position À174 of the IL-6 gene is not associated with
inflammatory bowel disease. Eur J Gastroenterol Hepatol
2001;13:45–7.
33. Koch W, Kastrati A, Bottiger C, et al. lnterleukin-10 and
tumor necrosis factor gene polymorphisms and risk of
coronary artery disease and myocar dial infarction.
Atherosclerosis 2001;159:137–44.
archives of oral biology 52 (2007) 268–272272